Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
View All Featured ArticlesHeadline News
Livdelzi improves ALP normalisation rates in Phase III PBC study
Allergan Aesthetics reports improved facial satisfaction in GLP-1 users after aesthetic treatments
Nipocalimab Sjögren’s data highlight symptom improvements most valued by patients
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Digital Transformation Strategy Development in Biologics Manufacturing: One site’s journey
Presented by Robert Dimitri, Associate Director, Digital and Data Sciences Lead at Takeda and Toni Manzano, PhD, Chief Science Officer, Bigfinite
01st October 2020
Single Use Process for Production of AAV Gene Therapy Products
Presented by Lance Marquardt, Associate Director -Upstream Processing Gene Therapy, Hopewell Biologics Manufacturing at PTC Therapeutics, Vikas Gupta, Vice President and GM Downstream Bioprocessing and Gene Therapy, Rachel Legmann, Senior Director of Technology, Gene Therapy at Repligen and Gilbert Huang, Senior Field Application Scientist at Repligen
26th May 2022
CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs)
Presented by Dr Friedrich von Wintzingerode, QC Lead iNeST (individual Neoepitope Specific Therapy), Roche and Nahuel Paolini, PhD, Sanquin Reagents
28th March 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Column Packing Protocol for Amsphere A3
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















